Recall Register

Food, drugs, devices › Amerisource Health Services

Drug recall: Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: American Health Packaging Col

FDA enforcement event 73166 · Class III · initiated 26 Jan 2016 · status Terminated · terminated 11 Jan 2017

DrugVoluntary: Firm initiated1 product recordColumbus, OH

Amerisource Health Services (Columbus, OH) initiated this drug recall on 26 Jan 2016; FDA lists 1 product record under event 73166, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 43% of the 288 drug enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 11 Jan 2017. Initiation: voluntary: firm initiated. Amerisource Health Services has 13 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Amerisource Health Services, Columbus, OH.

Reason for recall

"Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)"

Distribution

"Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-0660-2016Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: American Health Packaging Columbus, Ohio 43217, NDC 68084-877-25(carton), NDC 68084-877-95(individual dose)716 cartonsClass IIITerminated17 Feb 2016

Context

43%of 2016 drug events are Class III288 events that year
1product record in this eventfirm median: 1
13events on this register for the firm

Other enforcement events for Amerisource Health Services

InitiatedProduct (first record)TypeClassRecords
24 Oct 2017Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, OhiDrugClass II1
29 Aug 2017Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health PackaDrugClass III1
8 Feb 2017CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, CDrugClass II1
3 Feb 2017GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx ODrugClass II1
27 Oct 2016Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count DrugClass III1
13 Oct 2016AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx OnlyDrugClass III1
30 Sep 2016Paricalcitol Capsules, 1 mcg, packaged in 30 Capsules (5 x 6) per carton (NDC 60687-106-25); each blister card containinDrugClass III1
24 Aug 2016Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate TablDrugClass II10
4 Aug 2016buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila HeDrugClass III1
31 Mar 2016Fenofibrate Capsules (Micronized), 134 mg Capsules, 20-count Unit Dose Blister Packs per carton, Rx Only, Packaged and DDrugClass III2

All 13 events for Amerisource Health Services

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 11 Jan 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.